drugset / Trial / NCT04047810

Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)

NCT04047810

Phase 1 Completed 15 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

Researchers are trying to understand the effects of mesenchymal stem cells therapy in subjects with advance chronic obstructive pulmonary disease

Timeline

Start
2020-01-06
Primary completion
2023-11-21
Completion
2025-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 500000 cells/kg Intravenous
Subject mesenchymal stem cells Cell therapy 2e+06 cells/kg Intravenous